NG
NORTHROP GRUMMAN CORP /DE/ (NOC)·Q1 2025 Earnings Summary
Executive Summary
- Q1 2025 sales fell 7% to $9.47B and diluted EPS was $3.32, driven by a $477M pre-tax loss provision on B‑21 LRIP; segment operating margin compressed to 6.0% from 10.9% YoY .
- Revenue and EPS missed S&P Global consensus: $9.95B vs $9.47B actual and $6.26 EPS vs $3.32 actual; EBITDA also missed ($1.39B est. vs ~$1.04B actual)*. The B‑21 charge equated to $2.74 per share after tax .
- Guidance was reset: FY25 segment operating income cut to $4.2–$4.35B (from $4.65–$4.8B) and MTM‑adjusted EPS to $24.95–$25.35 (from $27.85–$28.25), while sales ($42.0–$42.5B) and FCF ($2.85–$3.25B) were reaffirmed .
- Record backlog rose to $92.8B, net awards totaled $10.8B, and management cited improving award timing, a stronger international pipeline (Q1 international book‑to‑bill 1.45x), and minimal tariff risk as supports for H2 ramp .
- The stock fell ~12.7% on the day of the release, with multiple law firms announcing investigations citing the miss and B‑21 charge as catalysts .
What Went Well and What Went Wrong
What Went Well
- Backlog reached a new record: $92.8B, with notable awards including $4.6B restricted programs, $1.1B for F‑35, $0.5B for IBCS, $0.3B Triton, and $0.3B E‑2 .
- Defense Systems (+4% sales, +15% operating income; OM 9.9%) benefited from Sentinel ramp and ammo programs; Mission Systems sales +6% on SABR, EW, and marine systems; Space Systems OM rate improved to 11.0% on favorable EACs .
- Management tone remained constructive on demand and awards: “record first quarter backlog” and reaffirmed sales and FCF guidance; international sales up 11% with 1.45x book‑to‑bill; over $1B international awards in Mission Systems .
What Went Wrong
- Aeronautics posted an operating loss (‑$183M; OM ‑6.5%), primarily from the $477M B‑21 LRIP loss provision due to a process change to accelerate the production ramp and higher material costs; company operating margin fell to 6.1% from 10.6% YoY .
- Company sales down 7% YoY, impacted by fewer working days, Space Systems wind‑down on restricted space/NGI, and contracting/material timing; segment OM fell to 6.0% from 10.9% .
- Cash usage intensified: operating cash flow ‑$1.565B and FCF ‑$1.821B on vendor payments and billing/collection timing; seasonality implies back‑half recovery but near‑term optics are weak .
Financial Results
Consolidated Performance vs Prior Year and Prior Quarter
Results vs S&P Global Consensus (Q1 2025)
Values retrieved from S&P Global.
Segment Sales and Profit
KPIs and Cash
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Global demand for our products remains strong…record first quarter backlog…reaffirming our sales and free cash flow guidance for the year.” — Kathy Warden, CEO .
- On B‑21: “We recognized an additional $477 million pretax loss…process change to enable a higher production rate and increased projected material costs.” — CEO prepared remarks .
- Outlook: “We continue to expect $42–$42.5 billion in 2025 sales…reaffirming free cash flow guidance of $2.85–$3.25 billion.” — CFO .
- International demand: “International book‑to‑bill of 1.45x and international sales up 11%…over $1B in international awards at Mission Systems.” — CEO .
- Tariffs: “Most potential costs are incorporated and covered under our U.S. government contracts…we do not see significant risk at this time.” — CEO .
Q&A Highlights
- B‑21 charge anatomy and recurrence risk: Majority tied to one‑time process change to enable higher rates; learning should not repeat; remaining risks largely inflation/materials .
- Cash impact of charge: No material impact in 2025; primarily spread through 2026–2028 .
- Sentinel profitability and restructuring: Confidence in design; cost‑plus structure; working with USAF to reduce cost/schedule; LRIP costs not yet contract‑estimated .
- Mission Systems margin path: Investments weigh near‑term; efficiency initiatives and mix support second‑half margin improvement .
- Award timing and H2 ramp: Large Q4 2024 awards, backlog ramps, and expected new competitive wins (esp. Space) underpin second‑half growth .
Estimates Context
- Q1 2025 missed consensus on revenue ($9.95B est. vs $9.47B actual), EPS ($6.26 est. vs $3.32), and EBITDA ($1.39B est. vs ~$1.04B actual)*; B‑21 LRIP loss provision was the key driver of EPS/margin shortfall .
- Street models likely shift lower for FY25 EPS and Aeronautics margins, but sales and FCF ranges were reaffirmed; management guides sequential sales growth in Q2 and stronger H2 driven by awards/backlog and improved award timing .
Values retrieved from S&P Global.
Key Takeaways for Investors
- The quarter’s headline miss was driven by a strategic process change to accelerate B‑21 production; while painful near‑term, management views it as derisking and supportive of profitable NTE and FRP units longer term .
- FY25 top‑line and FCF are intact; the reset is concentrated in segment OI and MTM‑adjusted EPS, with Aeronautics OM rate lowered materially; near‑term multiple risk persists until H2 execution is evident .
- Backlog and international momentum (1.45x book‑to‑bill) provide cushion; watch cadence of delayed awards converting in Q2/Q3 and competitive wins in Space .
- Cash flow remains back‑half weighted; Q1 cash usage was seasonal and amplified by working capital; monitor vendor payment cadence and collections in Q3/Q4 .
- Tariff/macro risks appear manageable given contract structures and domestic sourcing; focus instead on inflation/material consumption assumptions within Aeronautics .
- Stock reaction was negative (~12.7% down on the day), with legal firms publicizing investigations; near‑term sentiment will hinge on clarity of B‑21 charge containment and award flow .
- Dividend increased post‑Q1 (to $2.31/qtr in May); debt issuance ($1.0B notes) supports flexible capital deployment amid guidance reset .
Additional Notes
- Non‑GAAP items: FY25 guidance references MTM‑adjusted EPS and segment operating income; segment OM excludes certain corporate items and FAS service costs .
- Two working days fewer than Q1 2024 modestly impacted sales, alongside known Space Systems wind‑downs and timing factors .
- B‑21 after‑tax per‑share impact: $2.74; supplemental per‑share pension effects also disclosed (net FAS/CAS +$0.99/sh) .